Chemical Structure : BXY-14
货号: PC-26302Not For Human Use, Lab Use Only.
BXY-14 is a highly potent TLR2 agonist, stimulates TNF-α release with EC50 of 2.2 nM and 1.8 nM in human THP-1 cells and mBMDCs respectively.
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
BXY-14 is a highly potent TLR2 agonist, stimulates TNF-α release with EC50 of 2.2 nM and 1.8 nM in human THP-1 cells and mBMDCs respectively.
BXY-14 exhibited slightly stronger TLR2-activating activity than Diprovocim in hPBMCs, with EC50 values of 0.58 nM.
BXY-14 at 10 mg/kg induced stronger total IgG, IgG1, and IgG2c responses compared to Diprovocim in C57BL/6J mice.
At 10 mg/kg, BXY-14 in combination with the anti-PD-L1 antibody atezolizumab exhibited stronger tumor growth inhibition than Diprovocim.
BXY-14 monotherapy (20 mg/kg) potently suppressed tumor growth and prolonged survival, mechanistically linked to its downregulation of PD-L1 in tumors.
| 分子量 | 646.90 | |
| 分子式 | C35H66O10 | |
| 外观性状 | Solid | |
| 储存条件 |
|
|
| Solubility |
10 mM in DMSO |
|
1. Hongbin Jia, et al. J Med Chem. 2026 Mar 1. doi: 10.1021/acs.jmedchem.5c03709.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright